Upper respiratory tract infections (URTIs) Respiratory Upper respiratory tract infections (URTIs)
Conditions
Interventions
Upper respiratory tract infection (URTI) scores will be taken during an 8 week pre-treatment period. After this, these secores are used to divide the subjects into lower and higher strata. From each o
Sponsors
University of Wolverhampton
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 2. Generally healthy
Exclusion criteria
Exclusion criteria: 1. Gastrointestinal ailments at the time of the study 2. Previous anaphylactic shock 3. Proneness to food allergies (specifically including sunflower seeds) 4. Severe eczema 5. Autoimmune disorders such as lupus or rheumatoid arthritis 6. Pregnant or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper respiratory tract infection incidence and severity, assessed at the baseline and weekly for the 8 week trial period using the severity scale of Grimm and Muller | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The following baseline personal data, assessed by study investigators on a study-designed form following recruitment and prior to week 1 of the intervention dose period: 1.1. Gender 1.2. Age 1.3. BMI 2. The following lifestyle information, assessed using a self-report questionnaire at approximately week 4 of the intervention dose period: 2.1. Accomodation 2.2. Transport 2.3. Dietary supplements 2.4. Stress 2.5. Alcohol intake 2.6. Smoking 2.7. Exercise 3. Diet, assessed using a self-report diet diary form at week 4 of the intervention dose period 4. Subjective perceptions of benefit, side-effects and dose identification, assessed by questionnaire at week 8 of the intervention dose period | — |
Countries
United Kingdom
Outcome results
None listed